Evidence map›Paper›PMID 30410055›Full record

ArticleScientific reports2018

Heterogeneous Fenton Reaction Enabled Selective Colon Cancerous Cell Treatment.

Kuan-Ting Lee, Yu-Jen Lu, Shao-Chieh Chiu, Wen-Chi Chang, Er-Yuan Chuang, Shih-Yuan Lu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 22 citations in OpenAlex.

  1. Engineered ZnACS applied nano materials · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kuan-Ting LeeDepartment of Chemical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan, Republic of China.
Yu-Jen LuDepartment of Neurosurgery, Chang Gung Memorial Hospital, Taoyuan, 33302, Taiwan, Republic of China.
Shao-Chieh ChiuCenter for Advanced Molecular Imaging and Translation, Chang Gung Memorial Hospital, Taoyuan, 33302, Taiwan, Republic of China.
Wen-Chi ChangCenter for Advanced Molecular Imaging and Translation, Chang Gung Memorial Hospital, Taoyuan, 33302, Taiwan, Republic of China.
Er-Yuan ChuangGraduate Institute of Biomedical Materials and Tissue Engineering, Taipei Medical University. College of Biomedical Engineering, International PhD program of Biomedical Engineering and Translational Therapies, Taipei, 11042, Taiwan, Republic of China. eychuang@tmu.edu.tw.
Shih-Yuan LuDepartment of Chemical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan, Republic of China. sylu@mx.nthu.edu.tw.ORCID http://orcid.org/0000-0003-3217-8199
Chang Gung Memorial Hospital · TWNational Tsing Hua University · TWTaipei Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A selective colon cancer cell therapy was effectively achieved with catalase-mediated intra-cellular heterogeneous Fenton reactions triggered by cellular uptake of SnFe

Indexed as

Caco-2 CellsCatalaseCell ProliferationCell SurvivalColonic NeoplasmsFerric CompoundsHumansHydrogen PeroxideMetal NanoparticlesOrganotin CompoundsReactive Oxygen SpeciesCatalaseFerric CompoundsHydrogen PeroxideOrganotin CompoundsReactive Oxygen Species

Identifiers

PMID30410055
PMCPMC6224383
OpenAlexW2899441235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.